University of Calgary details SPRINT-KIDS study results
2Sep 14 5:40 PM · 9d ago · 2 articles · 1 source · development 2 of 4
The university's release, echoed by Medical Xpress, describes the JAMA Network Open study analyzing 2024-2025 RSV season data from seven pediatric hospitals in Ontario and Quebec, with lead researchers quantifying effectiveness against hospitalization and ICU admission.
byteseu.com
“The results were dramatic. Nirsevimab effectiveness against hospitalizations was 79 per cent, and 97 per cent against ICU admissions.”
Dr. Sarah Buchan
Dr. Sarah BuchanFirst author; scientific lead, Communicable Disease Control, Public Health OntarioDr. Stephen FreedmanSenior author; SPRINT-KIDS project lead, University of CalgarySPRINT-KIDS NetworkResearch surveillance network
The whole story articlespostscommentsthe bright band is this development · numbered dots are the others · click one to jump